<SEC-DOCUMENT>0001104659-25-056160.txt : 20250604
<SEC-HEADER>0001104659-25-056160.hdr.sgml : 20250604
<ACCEPTANCE-DATETIME>20250604060302
ACCESSION NUMBER:		0001104659-25-056160
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250604
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250604
DATE AS OF CHANGE:		20250604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sagimet Biosciences Inc.
		CENTRAL INDEX KEY:			0001400118
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				205991472
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41742
		FILM NUMBER:		251021821

	BUSINESS ADDRESS:	
		STREET 1:		155 BOVET RD., SUITE 303
		CITY:			SAN MATEO
		STATE:			CA
		ZIP:			94402
		BUSINESS PHONE:		(650) 561-8600

	MAIL ADDRESS:	
		STREET 1:		155 BOVET RD., SUITE 303
		CITY:			SAN MATEO
		STATE:			CA
		ZIP:			94402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	3-V Biosciences, Inc.
		DATE OF NAME CHANGE:	20070521
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2517101d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:sgmt="http://sagimet.com/20250604">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_sgmt_sagimet.com_20250604 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250604_20250604 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001400118 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000004" name="dei:EntityCentralIndexKey">0001400118</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sgmt-20250604.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-06-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001400118</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-04</xbrli:startDate>
        <xbrli:endDate>2025-06-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_90D_edei--DocumentType_c20250604__20250604_zj731qLc8kM8"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90C_edei--DocumentPeriodEndDate_c20250604__20250604_zMVHrE5Bc21"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">June 4, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityRegistrantName_c20250604__20250604_zoYyBMlNT5Zj"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000011" name="dei:EntityRegistrantName">SAGIMET BIOSCIENCES INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20250604__20250604_zOERtxbVkIbd"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font-size: 10pt; text-align: center; width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20250604__20250604_zwJQmTJafKlf"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000013" name="dei:EntityFileNumber">001-41742</ix:nonNumeric></span></b></span></td>
    <td style="font-size: 10pt; text-align: center; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20250604__20250604_zK0n5wjbS8y7"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000014" name="dei:EntityTaxIdentificationNumber">20-5991472</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of incorporation)</b></p></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Commission</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>File Number)</b></p></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(I.R.S. Employer</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Sagimet Biosciences Inc.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityAddressAddressLine1_c20250604__20250604_zspGfgGgvHZe"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000015" name="dei:EntityAddressAddressLine1">155 Bovet Road</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20250604__20250604_z46OgLvYP3zg"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite&#160;303</ix:nonNumeric></span>,</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20250604__20250604_zEKOo8oQHC9l"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000017" name="dei:EntityAddressCityOrTown">San Mateo</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20250604__20250604_z8IxPIx2qSW9"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20250604__20250604_zbM031zMDgO5"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000019" name="dei:EntityAddressPostalZipCode">94402</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of principal executive offices, including
zip code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_90F_edei--CityAreaCode_c20250604__20250604_zUYP6GRRqpJf"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000020" name="dei:CityAreaCode">650</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20250604__20250604_zXGUKFnlapEb"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000021" name="dei:LocalPhoneNumber">561-8600</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number, including
area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Former Name or Former Address, if Changed Since
Last Report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 3%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_907_edei--WrittenCommunications_c20250604__20250604_zPtOs7Yztpm2"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: left; font-size: 10pt; width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant
    to Rule&#160;425 under the Securities Act (17 CFR 230.425) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 3%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90F_edei--SolicitingMaterial_c20250604__20250604_zRwzgIpuzZ8c"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: left; font-size: 10pt; width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant
    to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 3%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90A_edei--PreCommencementTenderOffer_c20250604__20250604_zTJktKTXdDFj"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: left; font-size: 10pt; width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 3%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20250604__20250604_zefGmDmuLbq3"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: left; font-size: 10pt; width: 97%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications
    pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; font-size: 10pt; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Title of each class</span></span></td>
    <td style="white-space: nowrap; font-size: 10pt; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Trade<br/>
Symbol(s)</span></span></td>
    <td style="white-space: nowrap; font-size: 10pt; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Name of each exchange on which registered</span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20250604__20250604_zJgsnnOS84Ph"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000026" name="dei:Security12bTitle">Series&#160;A Common Stock, $0.0001 par value per share</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--TradingSymbol_c20250604__20250604_zDvjpRN2jMHh"><ix:nonNumeric contextRef="AsOf2025-06-04" id="Fact000027" name="dei:TradingSymbol">SGMT</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The <span id="xdx_90F_edei--SecurityExchangeName_c20250604__20250604_zaIGf3hBHdn2"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company </span><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20250604__20250604_zSwZL8s0mhue"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">x</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_902_edei--EntityExTransitionPeriod_c20250604__20250604_zLSePuHzmJ15"><ix:nonNumeric contextRef="AsOf2025-06-04" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; width: 10%"><span style="background-color: white"><b>Item 7.01</b></span></td>
    <td style="font-size: 10pt; text-align: justify; width: 90%"><span><b>Regulation FD&#160;Disclosure</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June&#160;4, 2025, Sagimet Biosciences Inc. (the &#8220;Company&#8221;)
issued a press release announcing that (i)&#160;denifanstat met all primary and secondary endpoints in a Phase 3 clinical trial for the
treatment of moderate to severe acne vulgaris conducted by the Company&#8217;s license partner Ascletis Bioscience Co. Ltd. (&#8220;Ascletis&#8221;)
in China and (ii)&#160;the Company recently initiated a Phase 1 first-in-human clinical trial with a second FASN inhibitor, TVB-3567,
that is planned to be developed for acne in the U.S. The full text of the press release issued in connection with this announcement is
furnished as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K and incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">The information in Item 7.01
of this Current Report on Form&#160;8-K, including the information set forth in Exhibit&#160;99.1, is being furnished and shall not be
deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
nor shall Exhibit&#160;99.1 furnished herewith be deemed incorporated by reference in any filing under the&#160;Securities Act of 1933,
as amended, or the&#160;Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; width: 10%"><b>Item 9.01</b></td>
    <td style="font-size: 10pt; width: 90%"><b>Financial Statements and Exhibits</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>(d)&#160;Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.25pt; padding-left: 3.25pt; text-align: center; width: 8%">Exhibit<br/>
No.</td>
    <td style="vertical-align: top; padding-right: 3.25pt; padding-left: 3.25pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 3.25pt; padding-left: 3.25pt; width: 90%">Document</td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 3.25pt; padding-left: 3.25pt"><a href="tm2517101d1_ex99-1.htm">99.1</a></td>
    <td style="vertical-align: top; padding-right: 3.25pt; padding-left: 3.25pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.25pt; padding-left: 3.25pt"><a href="tm2517101d1_ex99-1.htm">Press Release of Sagimet Biosciences Inc., dated June&#160;4, 2025.</a></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 3.25pt; padding-left: 3.25pt">104</td>
    <td style="vertical-align: top; padding-right: 3.25pt; padding-left: 3.25pt">&#160;</td>
    <td style="vertical-align: bottom; padding-right: 3.25pt; padding-left: 3.25pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2" style="vertical-align: bottom">Sagimet Biosciences Inc.</td></tr>
  <tr>
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">Date: June&#160;4, 2025</td>
    <td style="vertical-align: bottom">By: </td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom">/s/ David Happel</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">David Happel</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">Chief Executive Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUqXfPExsYgsQiR63XKMJd2R2a30k/rLNiUaBobh3nOvEDOxobVukOG8KnIose0a5RAKrJHRXNE70u0uAX8LvGnrWBk3vj8wJc+gZ+K5lBcvjNantlglEMaLaLmQS4hkEodw3Ivgq6dkal2hcVo1oEwFR6aONTrFw5RQqp4MtcNYdUK2mkwC0Tyc5DfIMJJwoKd6Ed8t5Hkqgtk4gdgwPTrvynqH5ktC1mDr6+xE/zf4AAXESos= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2517101d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="tm2517101d1_ex99-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sagimet Biosciences Announces Positive Phase
3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner Ascletis</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Denifanstat met all primary and secondary endpoints
versus placebo</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Denifanstat was well tolerated</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Oral FASN inhibitors offer a novel mechanism
of action for the potential treatment of moderate to severe acne</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Sagimet initiated first-in-human Phase 1 clinical
trial of a second FASN inhibitor, TVB-3567, that is planned to be developed for acne in the U.S.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>San Mateo,
Calif., June&nbsp;4, 2025</B></FONT> &ndash; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing
novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today reported denifanstat met all primary and secondary endpoints
in a Phase 3 clinical trial for the treatment of moderate to severe acne vulgaris conducted by Sagimet&rsquo;s license partner Ascletis
Bioscience Co. Ltd. (Ascletis) in China. Denifanstat is a once-daily oral small molecule fatty acid synthase (FASN) inhibitor being developed
by Ascletis as ASC40 for acne in China and by Sagimet for MASH in the rest of world. Additionally, Sagimet recently initiated a Phase
1 first-in-human clinical trial with a second FASN inhibitor, TVB-3567, that is planned to be developed for acne in the US.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;We are highly encouraged by the positive results from Ascletis&rsquo;
Phase 3 acne trial in China,&rdquo; said David Happel, Chief Executive Officer of Sagimet. &ldquo;FASN inhibition represents a novel potential
approach to treat moderate to severe acne vulgaris, a widespread condition impacting more than 640 million people worldwide. These positive
data support the rationale for our development of our FASN inhibitor TVB-3567 for moderate-to-severe acne and add to the body of evidence
of the broad consequences of unchecked overactivity of FASN.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;It is very exciting to see this novel oral acne product candidate
progressing through development in light of the limited innovation within the acne space over the past 40 years,&rdquo; said Dr.&nbsp;Neal
Bhatia, Director of Clinical Dermatology at Therapeutics Clinical Research in San Diego and a past Vice President of the American Academy
of Dermatology. &ldquo;These data demonstrate the significant clinical response that a FASN inhibitor can achieve for moderate to severe
acne patients by addressing the overproduction of sebum and the inflammatory cascade, two of the primary pathways of acne, and most importantly
through a novel mechanism of action. With currently available treatments either showing limited efficacy, high potential for irritation,
or risks of antibiotic resistance, control of acne through new modes of action is more critical now than ever.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Over 50 million people suffer from acne in the US, making it one of
the most prevalent skin diseases that physicians address annually. Patients with acne vulgaris have increased sebum production compared
to non-acne populations which contributes to the pathogenesis of the disease. Increased sebum production is due to increased de novo lipogenesis
(DNL) locally in the sebocytes. FASN is the last committed step in the DNL pathway which produces the majority (&gt;80%) of key sebum
lipids such as palmitate and sapienic acid in acne, and FASN also contributes to inflammatory pathways. Inhibition of FASN is therefore
an attractive therapeutic approach to address acne. In two separate denifanstat Phase 1 clinical trials, Sagimet collected sebum as a
non-invasive approach to assess FASN pharmacodynamic activity and showed that use of denifanstat led to significant reductions in sapienic
acid, a sebum fatty acid produced only by de novo lipogenesis, confirming FASN inhibition. These results provided mechanistic proof of
concept for FASN inhibition in sebum and provided a basis for Ascletis&rsquo; successful Phase 2 and 3 clinical trials of denifanstat
in acne in China.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Clinical Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Phase
3 clinical trial (</FONT><U>NCT06192264</U>) was a randomized, double-blind, placebo-controlled, multicenter clinical trial in China
to evaluate the safety and efficacy of denifanstat for the treatment of patients with moderate to severe acne. The 480 enrolled patients
were randomized 1:1 into two treatment arms to receive denifanstat 50mg or placebo, once daily for 12 weeks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Primary endpoints included the percentage of treatment success (defined as an Investigator&rsquo;s Global
Assessment (IGA) score of 0 (clear) or 1 (almost clear) with at least a 2-point decrease from baseline), the percentage change in total
lesion count, and the percentage change in inflammatory lesion count.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Ascletis reported that denifanstat met all the primary and secondary endpoints. Efficacy results are
summarized in Table 1 below.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Table 1: Efficacy data from Phase 3 trial of Denifanstat (ASC40)
in acne vulgaris</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse; margin-left: 0.25in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 36%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Endpoints</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; width: 23%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">50mg denifanstat, <BR>
oral, once daily</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(n=240)</P></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; width: 17%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Placebo, oral, <BR>
once daily</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(n=240)</P></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Placebo</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">adjusted</P></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; width: 11%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>p</I></FONT> <FONT STYLE="font-size: 10pt">value</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">% Treatment success (IGA)</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.2</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.6</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.6</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;0.0001</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">% Change in total lesion count</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-57.4</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-35.4</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-22.0</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;0.0001</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">% Change in inflammatory lesion count</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-63.5</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-43.2</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT><FONT STYLE="font-size: 10pt">20.3</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;0.0001</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">% Change in non-inflammatory lesion count </FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-51.9</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-28.9</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT><FONT STYLE="font-size: 10pt">23.0</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;0.0001</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absolute change in total lesion count </FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-58.3</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-36.2</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-22.1</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;0.0001</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Absolute change in inflammatory lesion count </FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-26.6</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-18.4</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT><FONT STYLE="font-size: 10pt">8.2</FONT></TD>
    <TD STYLE="padding: 1pt 5.4pt; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lt;0.0001</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Source: Ascletis Press Release issued June&nbsp;3<SUP>rd</SUP>,
2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ascletis reported that denifanstat was generally well-tolerated. Following
12 weeks of once-daily oral administration at 50 mg, the incidence rates of treatment-emergent adverse events (TEAE) were comparable between
denifanstat and placebo. No incidence rate of TEAEs in any category exceeded 10%. Only two categories of TEAEs had an incidence rate of
more than 5% (dry skin and dry eye reported in 6.3% and 5.9 % of denifanstat-treated subjects versus 2.9% and 3.8% in placebo-treated
subjects, respectively). All denifanstat-related adverse events (AEs) were mild or moderate. There were no denifanstat-related grade 3
or 4 AEs and no denifanstat-related serious AEs (SAEs). No deaths were reported.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These Phase 3 results confirm that FASN inhibition represents a potential
therapeutic approach within acne. Ascletis has indicated that it plans to submit denifanstat for approval to the China National Medical
Products Administration. Building on Ascletis&rsquo; positive Phase 3 results, Sagimet has recently initiated a Phase 1 first-in-human
clinical trial with a second oral FASN inhibitor drug candidate, TVB-3567, that is planned to be developed for acne in the US.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About&nbsp;Sagimet Biosciences</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sagimet
is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional
metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Sagimet&rsquo;s lead drug
candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction
associated steatohepatitis (MASH). FASCINATE-2, a Phase 2b clinical trial of denifanstat in MASH with liver biopsy-based primary endpoints,
was successfully completed with positive results. Denifanstat has been granted Breakthrough Therapy designation by the FDA for the treatment
of non-cirrhotic MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), and end-of-Phase 2 interactions
with the FDA have been successfully completed, supporting the advancement of denifanstat into further development. Sagimet has recently
initiated a Phase 1 first-in-human clinical trial with a second oral FASN inhibitor drug candidate, TVB-3567, that is planned to be developed
for acne in the US. For additional information about Sagimet, please visit&nbsp;</FONT><U>www.sagimet.com</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About Acne</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">There are 5.1 million acne patients in the
U.S. who are treated by dermatologists annually, and a total U.S. acne market of over 50 million people. <SUP>1,2 </SUP>There is no cure
for acne; and due to its pathology, most patients require chronic management and multiple courses of treatment for flare control annually.
Additionally, adherence to topical therapies is lower than with oral agents, with an estimated 30% to 40% of patients not adhering to
their topical treatments. <SUP>3</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">1</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E et al. The burden of skin diseases: 2004 a joint project of the
American Academy of Dermatology Association and the Society for Investigative Dermatology. Journal of the American Academy of Dermatology
2006;55:490-500.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">American Academy of Dermatology/Milliman. Burden of Skin Disease. 2017.&nbsp;www.aad.org/BSD.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in">3</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">Purvis CG, Balogh EA, Feldman SR. Clascoterone: How the Novel Androgen Receptor Inhibitor Fits Into the Acne Treatment Paradigm. Ann
Pharmacother. 2021;55(10):1297-1299. doi:10.1177/1060028021992055.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">This press release contains forward-looking
statements within the meaning of, and made pursuant to the safe harbor provisions of, The Private Securities Litigation Reform Act of
1995. All statements contained in this press release, other than statements of historical facts or statements that relate to present facts
or current conditions, including but not limited to, statements regarding: the expected timing of the presentation of data from ongoing
clinical trials, Sagimet&rsquo;s clinical development plans and related anticipated development milestones, Sagimet&rsquo;s cash and financial
resources and expected cash runway. These statements involve known and unknown risks, uncertainties and other important factors that may
cause Sagimet&rsquo;s actual results, performance or achievements to be materially different from any future results, performance or achievements
expressed or implied by the forward-looking statements. In some cases, these statements can be identified by terms such as &ldquo;may,&rdquo;
 &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;aim,&rdquo; &ldquo;seek,&rdquo;
 &ldquo;anticipate,&rdquo; &ldquo;could,&rdquo; &ldquo;intend,&rdquo; &ldquo;target,&rdquo; &ldquo;project,&rdquo; &ldquo;contemplate,&rdquo;
 &ldquo;believe,&rdquo; &ldquo;estimate,&rdquo; &ldquo;predict,&rdquo; &ldquo;forecast,&rdquo; &ldquo;potential&rdquo; or &ldquo;continue&rdquo;
or the negative of these terms or other similar expressions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The forward-looking
statements in this press release are only predictions. Sagimet has based these forward-looking statements largely on its current expectations
and projections about future events and financial trends that Sagimet believes may affect its business, financial condition and results
of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks,
uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Sagimet&rsquo;s control,
including, among others: the clinical development and therapeutic potential of denifanstat or any other drug candidates Sagimet may develop;
Sagimet&rsquo;s ability to advance drug candidates into and successfully complete clinical trials within anticipated timelines; Sagimet&rsquo;s
relationship with&nbsp;Ascletis, and the success of its development efforts for denifanstat; the accuracy of Sagimet&rsquo;s estimates
regarding its capital requirements; and Sagimet&rsquo;s ability to maintain and successfully enforce adequate intellectual property protection.
These and other risks and uncertainties are described more fully in the &ldquo;Risk Factors&rdquo; section of Sagimet&rsquo;s most recent
filings with the&nbsp;Securities and Exchange Commission&nbsp;and available at&nbsp;</FONT><U>www.sec.gov</U>. You should not rely on
these forward-looking statements as predictions of future events. The events and circumstances reflected in these forward-looking statements
may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Moreover,
Sagimet operates in a dynamic industry and economy. New risk factors and uncertainties may emerge from time to time, and it is not possible
for management to predict all risk factors and uncertainties that Sagimet may face. Except as required by applicable law, Sagimet does
not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future
events, changed circumstances or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investor
Contact:</FONT><BR>
Joyce Allaire&nbsp;<BR>
LifeSci Advisors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>JAllaire@LifeSciAdvisors.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Media Contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michael Fitzhugh</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">LifeSci Advisors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>mfitzhugh@lifescicomms.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2517101d1_ex99-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2517101d1_ex99-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !S 2T# 2(  A$! Q$!_\0
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M;$J,]5 /.,@D]#U'MS1==U]Z_P P+%%0><<XPO?@D]O<#!Q[$CN.*<DA8D$
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M1;MX/''C;_BW'@%;6?R-2CUSQ'#<6]WJVF%5>3[=H&CK?:I921QND6HQV+R
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M.0!PJEB<+T .!TK\E?\ @L__ ,FK^&O^RT^%O_3!XNK]:-$_Y!.E?]@K3O\
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MX?MDUFVT<0+X<MO&LU_X9N)X;:&T1;&*Y37I/&X2.U.^&$/'*3N91W?['F>
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M$DOBZ):)=DM$K):)'7>^O?7[TG^H4445J 4444 %%%% !1110 4444 %%%%
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DK_NC^0IU%%*'Q/T_4 HHHK4 HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>sgmt-20250604.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa6PybOdzZR+WYkxtmB2bdnK/y4mi+8ikCxF6cM2oaIG -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:sgmt="http://sagimet.com/20250604" elementFormDefault="qualified" targetNamespace="http://sagimet.com/20250604">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sagimet.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="sgmt-20250604_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sgmt-20250604_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>sgmt-20250604_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>sgmt-20250604_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sagimet.com/role/Cover" xlink:href="sgmt-20250604.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sagimet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  04,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SAGIMET BIOSCIENCES INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001400118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-5991472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">155 Bovet Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Mateo<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">561-8600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Series&#160;A Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGMT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2517101d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sagimet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>sgmt-20250604.xsd</File>
    <File>sgmt-20250604_lab.xml</File>
    <File>sgmt-20250604_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2517101d1_8k.htm">tm2517101d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2517101d1_8k.htm": {
   "nsprefix": "sgmt",
   "nsuri": "http://sagimet.com/20250604",
   "dts": {
    "schema": {
     "local": [
      "sgmt-20250604.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "sgmt-20250604_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgmt-20250604_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2517101d1_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://sagimet.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-06-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2517101d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-06-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2517101d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sagimet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-25-056160-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-056160-xbrl.zip
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MMUV:MW/6$K;V I,5?!LO_?M?4CY]Y(K'^SM ?2I$_E9$Y".,E'AA0W!'B,>
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MT<G]>'QW4)2DY7(LC#M>:I?/ZS>U#CJM-]N5>JU1@8FQWJ@D=Z^+E<+;JTV
M 4$Y=P-K1C'"-K)-HO!R2$4:")C9,0@!X!76-D/0@I4PW-4)$*CK( *%K^O&
MP;+Y9Q.KJO]Y8Y2!O'&6#BI4U[%I0]+G_R8JBV-F^?!'Q&*:@G5?;I!=>L7'
M,5.#1/C)(U 2)>D9_DR&IZW"7H.C>WBHZ=/B6TPL8%K#^.N&0BV(9&*5M,T@
M"%3<9<0*55?X0K/68I/NMZ=Z5WUOL.(+N+S29<2TZ(B;UE*TDI>=Y55:XZ4J
MT?$8XMZKON+]RM2?TU)VUUHJA+1TIND$V.D2*UHEX\NOP\XE[EWIO?>'I\RR
MQ.=X^6*(E,A*!UGY(^2[<R_(A^3;P9.ZM[*C".MZ3=A7:2,W?NRV"].#]PL[
M8FEN!1'QDIQ.Y X/I>S!NJ*'OZQ- I7WR^ZF$.&L/#VED#-:Z!%21EO51/(Z
MFRAV2P+,7%HP?,PFJ)"M[EP0%3H<:K;]<7QS#T:N(?TBENO)5K*=1+6AJ=,I
ML3Z([[ GH09-AMF?N4A*Y!.E7250'U.SM-V=+72J45O1Q"(Z@MDR^1'YX>OY
M15E5+6+;WH]KS2!2=%2US?->_[P_NOA!WA]5<\M1-8* >$G*Y= I'8'$6A2K
M*Z+J/EID37J#-3F:M6R^V;\>?;_-O/3?SUI^'=9DJ" <C1'7ZC+IS"K6?AO#
MJ,"O3:M#QT:T[&I735J@7R\JA_K[97>P4G9S]" YH/8&YBFZMCT4HC@2<UW3
MNH7$%F:<%3ETH3ZYK4_DY_;?ASO,H0LK^5X@,EZJ@/X N*'A%=PO,7\6Q?PM
M!8KT'YJYNGSHWJ0STLM-M=_,O5^CARLY"U$0+QUFL^G7TZ8=5\\>6;QT-BV0
MM69B'9$)41RFC7A%#7,4API-NL/+U]B+9H(@5++#&GIW[*ZR$NYH98O@U79Q
M]_TV?]YJ/9N7[Z]AY- :5Q!GO)3/I5?8P9<EV\YX5%]32)EO!]1XM?JZ/[^[
M.C-T;-:Z[Z<\M#BTB#=>RN6E1"&?7L7"AYCR?+'JW_\JR-+!D0U==6)R.I$A
M" W:,93B^-,:<H,R5#9-'1)(2 \_1+QG$-NA.&J(A38+>1^]^ &"[:&*6%]7
M49O'[-@UMIFW2OUI)*R3'M3CE0%1GL3V 39A\H*XR,O#+IV@+M'IF+/*&[D$
M7%H*B2O4TW2P*J398&*,&"I18XPB6QLZ.L,&H8ZM3Y$-Z;[=FXKAW@#:!=1N
M%>#M6026,!V 8R%L3/VV'M6! CZ.SZH:K]3LXC\+F2N6</SEFE=7:_X&5C@[
M=M3*S-NCXDN)Y($7G?^V- :6P&MJQ_ J/3LZ1-^RIGWP_8690_G=&RQ=2G6"
M#7%(:R%XAQ8K(\ER=5\X6AF_PS\BUL\6W6A)FC-U'!YL=?7,XP?D%&0(F=Y&
MI* 3/)&?>7#M.ROG/,=:V"'D&X-[T@&JG+60G$DGH2/,O5$+5UNKRO_QN>WX
MG)_'M2E,B:!-H\]+)0C<>K3#M<8O_;KIO/PH*+MPN-!:]3)-G]C;YLR (;O<
MO.)J4A8G)#G@;:%-^)FO9=-)M^>7?[SM,WA;V?.V6XOP:80OZ(D#-#SML9J]
MWJI*I'/YQ*XZ]VKU;+-MZC6]+K1IL9JV3^Q]P%1""7"U,.D).LW "9R@)ZH)
M>:_[Q?VTED.Z _YQR4_ADH5HEZS;MD.L-QV3],Z'U:%SW7W.[,(Q<Z\XYA*%
M_YWNF2&)[)ZR@7MZ S[6/7\>7"#==NM<8A$U))3PJ<%YS/(J8!#$]@K>9=6[
MZCP('J+VY/O[QR?W>/ARB!H/-$82G&#"KPZ-+6Q&N,0KYQVRZ>V>=PA"$FA5
MHG@;WT4W6>3W)..E#K_ YQYN5 9(T;%MK^'^/\VN_*O8M;!*CKM6JA1K3X==
MJN_97SZ"WU^EWH9W9D]HE_B1CAH(.()OYO$A0@AKG"%9Y0YKB&;[XH@H5=U(
M.)7DKK#SZ)GYLF\;1K-=R-X.WK]X']J<7<3+8[(%\=@-=V7$)V?009M1Y6D?
M_6\ZR3>TD(DM-,*Z0Y#);Z8-7CO(]E.'K'8I>G^+ESL:Q&K7R:+E7AT]FJV&
M_'AS\1-R#VWLAI""T,]O.K^_!#LPX[YEP'Z.LOIX,JZ?]S*#TPO5>/?RIMA.
MYC$B:B=9+D09>) N'FQL%3^OVCT^UVD7Z^@&6T^$?:J4*FH#HVZH/.<DJ#M%
MBMC,@"%/$%:).-^VL,F@V0CT"PDKA]I'?8N.V2 &J:O)-QZPC532@W@MSE '
M5E'3.;1\R6)^MR*#]GC'@R-W*=7O#<A *R8_@\UWD0(9L-Q-R,L08U'7-N:@
M>28\'Q@ GOQU.>(N4+[7?VN>5F.N5I&O59_B]4O-#>O16NCXA4_&N:"BXA(1
M'2O:XQ_7!3L]'#B;';2**$69Y2Q6HA$',R)IBY<F:]:?G]7*HN+&]NRNWHLM
MQQ3?^O@N?&2 TI8V0 <0?H@.%2&$'X.*^M"QB>@%U(MM5B2>4M'$#JI[I9S;
M@L"E3[GICS5 S8W> /*AQ2(CS89Q$-2PH? %;*R(QTDXI?P=&Q5;JNUNL*JO
M%J>9/1PN3H/!*KE[)Y/#3C;IS"3AWIN*]K#K-KEU+EZ&E])F)YS66^S)I"-<
M;(FR#1=Y/JN3_;*[XX&[X9%WQP-WRW_YW?%MR_K7)VC+"Y AW9IL6;NB7%FR
M%2[G(X#Z[/ E14 NA"Y*@F7UKWP=((A<DB.PYP7VY3<4@N9@>L:PC-TB^"G1
M)1 >@$)34!S$F(] R*G8$&/0!G?W=,'NU_>VNLD@+:W<=$'W,-LZALH7$*E5
M1&)YR+UTP,@0'233TD_=A7IT;*;UIO,U]!D-'$>+]!W=/<YT5G5%6]5L1:?\
M:9"5%X%^U^(J7FH:B%\Z]FH>]^8Q]%UQH0'M\2R 'S^4TT=>*BD^24=?8AK?
MZ5 1ALR"G[BU(*_!D,M@PP!U<5N#% (SM*=Y.85*#*V'^<MZ#'%D6-?Y&5T@
M$*HR Y1%8+96^2?(@TRJ&8R?/0/XMP,.-X,47>-[#SID2#S+X5D1D!=CX+!,
M;$] UC*D*G\,AO#DQB9@C$"08A T<O0^MGA!!3@<D7]UW7-K ;;$&4M=4X@!
M^$QL,8.?" 1M$P8CY\*!,4ETS=0D+]R$;/Q.<^$8J#* A$QPMJ?Y,@@@!('Q
M]0U]"DQ")H&9D*7+JP3)G&6S!(28@0-*763=30$]B:&S<KL!0 9:5V/4 @/X
M=IK(Y/('^S&A "#=U$$K/+6DJ$N@_AT1G9K$32R%>(!<3MH=OSK$UTAZ#BA'
M//SD98)A'7NJU_@I)0 L<DB7*%&T>B;@[AEI=JSG6(9F#SB#_-T"0:@KC\/#
MI,2I$L,JCF7Q$=Y3 -SE0D<2N2CGM\H &A3_!&CH<EEZKUEMKT[>LN.M%]6X
M[#5C]HXBE_ LRL7\-8$WY!0X%"Q4%X1G@]_!)U 40%[2Q#ZWE2[A P,JXZXY
MX,[*"Y8NB:D$%*OZ4:&GZ43US%[8$Y07)K6).((?+B\*$0LL4<LA^]Q,\-"M
MAH(1*-C9][3]F$$MC\!ETYJSP6U%6*AP ,%!R):"1B3"#GBH=Z1UMGWI HY>
M'MJ/S8G>1S30/TCU/M\7(*9[F5_0W.65G_ N?IYVIAX@Q[OLKX3ILAV%N[Y+
M6G+;Z?UOECRLO>41RA^\S.!PEAFLDQ*$9G]^D=,OIL7='1[);.$*GHW9,\B_
M_:0/)=,K2=2>^L4WTR!CG].>UMAL7K*$A6JCNUAM1"2T1\@C.&%I_0&0F4G*
M.6Y$_M>\2)I_^\I690&LS1.\NU':H,E(>]TI%?(?<TU%X-Y40F['#<D+^I__
M6L[BSNC6I0(>@)'[?B8;RCGI0$I+JO1 )H>'"2DY8!!Z^#1RG,+14>3G\;\B
M]BV(=0W^;D5BU_(2.SYGKZ@%]I$J)LJE\B$Y$\]N527Q%S@_I1(J%,"(Q0\7
M4YU['U;$C<0J9AB)9P/VR+!+5)[S\#S%R\CKXHEMQ-_81JKG%E^2GV/B66<%
M2/[X%:#_EK6?W3U_4#]OE#MWK=KO>PTN'GJXS]V$>78TRTODUJQ#0BE]Q$Z.
MZD#.KF"'[[Z(RLQ]I<XKLVV0&S10\5(7? 'I?L]?=! EA=>!5R:. 6,$..RP
M ;4@,55W5,K^GEE8Y+)A5%P&2+SD.8G+\;>JAM7/=+PQ5WF\Y-*OYT6!D]%O
M]\H>A+MM.%?&Q4.)Q>79=X-9*UXZG1;1%E.\>"EEIV &&VDJNL"F2?3WL;;Q
M_/NN(9^%SLI (ST(2/Z;!4WQ9H'U_V?.SQRAIBE.D!>1N%7]FVP"?8YI>;?@
MUOD7(PJG#^*P@KBM/?^')LCEY.Q1K5WUG\I?6]U4N3=YE)MWS_>]V]K$_MZW
MOVJM?.;^ZN92E5LRSJ2?4M9U0[O#I[0[R!C-4:W:G-#N-^>I>5ZX,NK4)FF<
M:Y6OK,N+UGVC=I!VTD[YOG ].C>LOT^?,J/'POA2^:O_XZ^KG'ZJC!X;,"_K
M?;UV@Z_Q]?!K.SMXJE%UG*F/^L]Y]0GK\D#Y1B5:&Y^U\KC9Z%AGXUSKZ[.9
MO6%*X[MZ=R4/G\:5=&>JY*J]^LWEY9A>J?F:6F"YBZ?G/GO*]M7^^+9CC:;&
M\T7NB56D8=7*_S6II5YZV7+YOM:F]HDKD13_]S'$/[O"AGKI_P!02P,$%
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M"(X%]CIVO/(]-W+Y5ISRO:&YY6TX\9O)A4T!.+5-+/#QWL+]."+3.M#2L&;
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M4$L! A0#%     @ 8##$6L7#CVED$P  *6D  !(              ( !#A8
M '1M,C4Q-S$P,60Q7SAK+FAT;5!+ 0(4 Q0    ( & PQ%I^EQE5,1@   B!
M   6              "  :(I  !T;3(U,3<Q,#%D,5]E>#DY+3$N:'1M4$L%
3!@     %  4 20$   ="      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>tm2517101d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sgmt-20250604.xsd" xlink:type="simple"/>
    <context id="AsOf2025-06-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001400118</identifier>
        </entity>
        <period>
            <startDate>2025-06-04</startDate>
            <endDate>2025-06-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-06-04" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-06-04" id="Fact000004">0001400118</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-06-04" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-06-04" id="Fact000010">2025-06-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-06-04" id="Fact000011">SAGIMET BIOSCIENCES INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-06-04" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-06-04" id="Fact000013">001-41742</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-06-04" id="Fact000014">20-5991472</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-06-04" id="Fact000015">155 Bovet Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-06-04" id="Fact000016">Suite&#160;303</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-06-04" id="Fact000017">San Mateo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-06-04" id="Fact000018">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-06-04" id="Fact000019">94402</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-06-04" id="Fact000020">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-06-04" id="Fact000021">561-8600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-06-04" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-06-04" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-06-04" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-06-04" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-06-04" id="Fact000026">Series&#160;A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-06-04" id="Fact000027">SGMT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-06-04" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-06-04" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-06-04" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
